WO2024017716 - AN INJECTION DEVICE COMPRISING A CLOSURE CAP THAT CAN BE REMOVED TOGETHER WITH AN ELECTRONIC MODUL

National phase entry is expected:
Publication Number WO/2024/017716
Publication Date 25.01.2024
International Application No. PCT/EP2023/069234
International Filing Date 11.07.2023
Title **
[English] AN INJECTION DEVICE COMPRISING A CLOSURE CAP THAT CAN BE REMOVED TOGETHER WITH AN ELECTRONIC MODUL
[French] DISPOSITIF D'INJECTION COMPRENANT UN CAPUCHON DE FERMETURE POUVANT ÊTRE RETIRÉ AVEC UN MODULE ÉLECTRONIQUE
Applicants **
YPSOMED AG
Inventors
KÜHNI, Florian
BOSSHARD, Simon Martin
ZUMSTEIN, Dominik
SCHRUL, Christian
ETTER, Leoni
Priority Data
22186290.7   21.07.2022   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2084
EPO Filing, Examination, Granting8381
Japan Filing, Examination, Granting2170
South Korea Filing, Examination, Granting2060
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,435

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] An injection device for expelling fluid medicament comprising a housing (2) and a closure cap (17) closing the housing (2), The closure cap (17) being connected to the housing by a first releasable connection, and a printed circuit board (16c) comprising electronic elements, the printed circuit board (16c) being located in the closure cap (17). A first connector (17g) is located on the closure cap (17) and a second connector (16d) is located on the printed circuit board (16c). A second connection is configured to be established between the closure cap (17) and the printed circuit board (16c) by engaging the first and second connection means (17g, 16d) through a relative movement between the closure cap (17) and the housing (2) as the medicament delivery device is fully assembled.[French] Dispositif d'injection pour expulser un médicament fluide comprenant un boîtier (2) et un capuchon de fermeture (17) fermant le boîtier (2), le capuchon de fermeture (17) étant relié au boîtier par une première connexion libérable et une carte de circuit imprimé (16c) comprenant des éléments électroniques, la carte de circuit imprimé (16c) étant située dans le capuchon de fermeture (17). Un premier connecteur (17g) est situé sur le capuchon de fermeture (17) et un second connecteur (16d) est situé sur la carte de circuit imprimé (16c). Une seconde connexion est conçue pour être établie entre le capuchon de fermeture (17) et la carte de circuit imprimé (16c) par mise en prise des premier et second moyens de connexion (17g, 16d) par l'intermédiaire d'un mouvement relatif entre le capuchon de fermeture (17) et le boîtier (2) lorsque le dispositif d'administration de médicament est complètement assemblé.

Rejoining the server...